Back to Agenda
To Shape the Future of Patient Labeling Across Regions
Session Chair(s)
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
In this session we will discuss ongoing initiatives in the field of electronic labeling and look ahead to their potential impact on the future of digital health, with a particular focus on patient product information in the US, EU, Japan, and Asia. This session will also discuss how different approaches to electronic labeling may converge across regions, driving a new patient-centric focus to product information.
Learning Objective : Discuss how emerging trends for electronic labeling are impacting risk communication across the US, EU, Japan and Asia; Describe the challenges of provision of patient product information in the future; Discuss approaches to improving health literacy and adherence to patient labeling; Discuss the possibility of convergence of electronic labeling standards to drive patient centricity across regions.
Speaker(s)
Junko Sato, PhD
Associate Executive Director, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
PMDA’s Updates for Electronic Labeling Initiative and Patient-Centric Labeling in Japan
Elizabeth Scanlan, PhD, MSc
ePI Product Owner, European Medicines Agency, Netherlands
Electronic Product Information (ePI) in the EU: Key Principles and Beyond
Khyati Roberts, RPh
Retired, Retired, United States
Electronic Labeling in the US / Canada and A Global eLabeling Vision
Rie Matsui, RPh
Senior Director, Regional Labeling Head for APAC, Pfizer R&D Japan G.K., Japan
Dynamic Landscape in Asia for Electronic Labeling and Patient Labeling
Have an account?